BC
AH

Beaconlight Capital’s Accretive Health AH Stock Holding History

Beaconlight Capital’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-25,000
Closed -$270K – 37
2013
Q2 		$270K Buy
+25,000
New +$263K 0.29% 31

Other funds holding AH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Beaconlight Capital's AH Position: Q3 2013 in Review

Beaconlight Capital sold out of Accretive Health (AH) in Q3 2013, closing a stake of 25,000 shares — an estimated $270K sold.

Beaconlight Capital first reported a position in AH in Q2 2013 and held it in 1 quarter. The position peaked at $270K in Q2 2013. 99 funds tracked by Wall St. Rank hold AH as of Q3 2013.

  • Beaconlight Capital reported no remaining Accretive Health position as of Q3 2013 after selling out during the quarter.
  • Beaconlight Capital sold 25,000 Accretive Health shares in Q3 2013, an estimated $270K.
  • Beaconlight Capital first reported a position in Accretive Health in Q2 2013 and held it in 1 quarter.
  • Beaconlight Capital's Accretive Health position peaked at $270K in Q2 2013.
  • 99 funds tracked by Wall St. Rank held Accretive Health as of Q3 2013.

Based on Beaconlight Capital's 13F filing for Q3 2013, filed 14 Nov 2013.